{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20211122",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "69383",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213312Orig1s000Corrected_lbl.pdf",
              "date": "20211210",
              "type": "Label"
            },
            {
              "id": "69408",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213312Orig1s000Corrected_ltr.pdf",
              "date": "20211124",
              "type": "Letter"
            },
            {
              "id": "71970",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/213312Orig1s000TOC.html",
              "date": "20220830",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "14",
          "submission_status": "AP",
          "submission_status_date": "20260902",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "87148",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/213312Orig1s014ltr.pdf",
              "date": "20260904",
              "type": "Letter"
            },
            {
              "id": "87181",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213312s014lbl.pdf",
              "date": "20260911",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA213312",
      "sponsor_name": "AADI",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "FYARRO",
          "active_ingredients": [
            {
              "name": "SIROLIMUS",
              "strength": "100MG/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}